Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

PURPOSE: The Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial established perioperative epirubicin, cisplatin, and fluorouracil chemotherapy as a standard of care for patients with resectable esophagogastric cancer. However, identification of patients at risk for relap...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Smyth, Elizabeth C., Fassan, Matteo, Cunningham, David, Allum, William H., Okines, Alicia F.C., Lampis, Andrea, Hahne, Jens C., Rugge, Massimo, Peckitt, Clare, Nankivell, Matthew, Langley, Ruth, Ghidini, Michele, Braconi, Chiara, Wotherspoon, Andrew, Grabsch, Heike I., Valeri, Nicola
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2016
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019747/
https://ncbi.nlm.nih.gov/pubmed/27298411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.7692
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi